Patient_Reported_Outcome_Measures_in_Rheumatic_Diseases

363

Table 14.2

Mean MDHAQ/RAPID3 scores, laboratory measures, and medication at baseline and most recent visit in 34 patients with PMR

PMR patients (

n = 34)

Mean change

% Improvement

Baseline

Most recent visit

P value

MDHAQ: Patient self-reported measures

RAPID3, mean (SD)

12.2 (7.0)

8.5 (7.2)

0.02

3.7

30.7 %

MDHAQ-Function, mean (SD)

2.2 (2.1)

1.5 (1.7)

0.03

0.6

27.2 %

MDHAQ-Pain, mean (SD)

5.3 (2.9)

3.4 (3.4)

0.002

1.9

35.8 %

MDHAQ-PATGL, mean (SD)

4.7 (2.9)

3.1 (3.1)

0.01

1.6

34.0 %

RADAI-painful hip,

n (%)

22 (64.7 %)

12 (35.3 %)

0.02

29.4

45.4 %

RADAI-painful shoulder,

n (%)

27 (79.4 %)

17 (50 %)

0.02

10

37.0 %

MDHAQ-Fatigue, mean (SD)

3.9 (3.6)

3.5 (3.3)

0.54

0.4

10.5 %

Morning stiffness duration, minutes, mean (SD)

63.1 (97.7)

19.1 (34.1)

0.05

43.9

69.5 %

Laboratory measures

Abnormal ESR,

n (%)

25 (73.5 %)

14 (41.1 %)

0.007

32

43.5 %

Abnormal CRP,

n (%)

24 (70.6 %)

13 (38.2 %)

0.007

32

45.3 %

Medication

Prednisone dosage, mg, mean (SD)

12.2 (6.8)

4.3 (3.5)

<0.001

7.9

64.7 %

14 PROMs for Polymyalgia Rheumatica